Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
The legal panel was moderated by Cheryl Bruner, Esq. The panel included:Joseph Belluck, Esq., Belluck & Fox, LLPDawn Besserman, Esq., MHRFMKathy Farinas, Esq., Dean Omar
Mesothelioma is a cancer that affects a small amount of people who are exposed to asbestos. Why do some people develop mesothelioma and others do
Many patients and caregivers want to learn more about the diagnosis, looking to research studies and other data, but these studies are scientific and sometimes
The Mesothelioma Applied Research Foundation is seeking participants for a study focused on understanding the experiences and challenges of caregivers of mesothelioma patients. The study, which is
Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different
Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC). This session
A mesothelioma diagnosis and recurrence monitoring has many facets. Patients, when seeing their oncologists, may hear information about imaging, biopsies, pathology, and biomarkers and genetic
These sessions showcase case studies over dual compartment disease and immunotherapy vs. chemotherapy. These sessions are presented by:R. Taylor Ripley, MD, Baylor College of MedicineManish
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
